Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Shanghai Pharma to Raise $1.2 Billion in Hong Kong IPO

publication date: Sep 8, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shanghai Pharmaceuticals Holding Co. will stage an IPO in Hong Kong to raise 8 billion RMB ($1.2 billion) that it will use for acquisitions. A state-owned enterprise, Shanghai Pharma is a rival of Sinopharm (HKEX: 1099) in the China pharmaceutical distribution business, and its IPO seeks almost the same amount as Sinopharma’s IPO in Hong Kong one year ago. More details....

Stock Symbol: (SHEX: 601607)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners